AxoGen Debt to Equity Ratio 2006-2019 | AXGN

Current and historical debt to equity ratio values for AxoGen (AXGN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. AxoGen debt/equity for the three months ending December 31, 2019 was 0.01.
AxoGen Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-12-31 $0.00B $0.13B 0.01
2019-09-30 $0.00B $0.14B 0.02
2019-06-30 $0.00B $0.14B 0.02
2019-03-31 $0.00B $0.14B 0.02
2018-12-31 $0.00B $0.15B 0.00
2018-09-30 $0.00B $0.15B 0.00
2018-06-30 $0.00B $0.15B 0.00
2018-03-31 $0.02B $0.02B 0.82
2017-12-31 $0.02B $0.03B 0.79
2017-09-30 $0.02B $0.01B 1.93
2017-06-30 $0.02B $0.01B 1.80
2017-03-31 $0.02B $0.01B 1.67
2016-12-31 $0.02B $0.02B 1.36
2016-09-30 $0.03B $0.00B 22.65
2016-06-30 $0.03B $0.00B 8.93
2016-03-31 $0.03B $0.01B 5.13
2015-12-31 $0.03B $0.01B 3.01
2015-09-30 $0.03B $0.01B 2.29
2015-06-30 $0.03B $-0.00B -7.20
2015-03-31 $0.03B $-0.00B -37.13
2014-12-31 $0.03B $-0.01B -2.23
2014-09-30 $0.03B $-0.01B -2.77
2014-06-30 $0.03B $-0.01B -3.80
2014-03-31 $0.03B $-0.00B -7.11
2013-12-31 $0.03B $0.00B 185.68
2013-09-30 $0.02B $0.00B 5.91
2013-06-30 $0.02B $-0.01B -2.52
2013-03-31 $0.02B $-0.01B -3.74
2012-12-31 $0.02B $-0.00B -7.63
2012-09-30 $0.01B $0.00B 3.93
2012-06-30 $0.00B $0.00B 1.06
2012-03-31 $0.00B $0.00B 0.95
2011-12-31 $0.00B $0.01B 0.73
2011-09-30 $0.01B $0.01B 0.61
2011-06-30 $0.00B $0.01B 0.00
2011-03-31 $0.00B $0.01B 0.00
2010-12-31 $0.00B $-0.03B 0.00
2010-09-30 $0.00B $0.01B 0.00
2010-06-30 $0.00B $0.01B 0.00
2010-03-31 $0.00B $0.01B 0.00
2009-12-31 $0.00B $0.01B 0.00
2009-09-30 $0.00B $0.00B 0.00
2009-06-30 $0.00B $0.00B 0.00
2009-03-31 $0.00B $0.00B 0.00
2008-12-31 $0.00B $0.00B 0.00
2008-09-30 $0.00B $0.00B 0.00
2008-06-30 $0.00B $0.00B 0.00
2008-03-31 $0.00B $0.00B 0.00
2007-12-31 $0.00B $0.00B 0.00
2007-09-30 $0.00B $0.00B 0.00
2007-06-30 $0.00B $0.00B 0.00
2007-03-31 $0.00B $0.00B 0.00
2006-12-31 $0.00B $0.00B 0.00
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $0.00B $0.00B 0.00
2006-03-31 $0.00B $0.00B 0.00
2005-12-31 $0.00B $0.00B 0.00
2005-09-30 $0.00B $0.00B 0.00
2005-06-30 $0.00B $0.00B 0.00
2005-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.327B $0.107B
AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $122.500B 24.89
Intuitive Surgical (ISRG) United States $59.601B 44.20
Edwards Lifesciences (EW) United States $43.299B 37.17
ALCON INC (ALC) Switzerland $25.548B 0.00
DexCom (DXCM) United States $23.632B 140.99
IDEXX Laboratories (IDXX) United States $21.738B 52.20
Olympus (OCPNY) Japan $20.745B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $20.442B 13.54
Sysmex ADR (SSMXY) Japan $15.207B 42.86
Teleflex (TFX) United States $14.912B 28.84
STERIS (STE) Ireland $12.658B 26.99
SONOVA HOLDING (SONVY) Switzerland $11.597B 0.00
Varian Medical Systems (VAR) United States $10.447B 24.31
Hologic (HOLX) United States $10.369B 15.94
Masimo (MASI) United States $9.877B 57.51
SARTORIUS AG (SARTF) Germany $7.730B 68.68
ABIOMED (ABMD) United States $7.042B 37.12
Penumbra (PEN) United States $5.641B 165.90
Globus Medical (GMED) United States $4.442B 26.33
Integra LifeSciences Holdings (IART) United States $4.036B 17.44
Tandem Diabetes Care (TNDM) United States $3.953B 0.00
Wright Medical Group (WMGI) Netherlands $3.602B 399.71
Nevro (NVRO) United States $3.446B 0.00
Elekta AB (EKTAY) Sweden $3.343B 25.74
Nihon Kohden (NHNKY) Japan $2.937B 0.00
LivaNova (LIVN) United Kingdom $2.332B 17.01
Integer Holdings (ITGR) United States $2.093B 13.63
Cantel Medical (CMD) United States $1.445B 13.91
Glaukos (GKOS) United States $1.427B 0.00
Luminex (LMNX) United States $1.352B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 24.67
Veracyte (VCYT) United States $1.155B 0.00
Inogen (INGN) United States $1.125B 47.72
Silk Road Medical (SILK) United States $1.125B 0.00
ShockWave Medical (SWAV) United States $1.104B 0.00
OPKO Health (OPK) United States $0.931B 0.00
Mesa Laboratories (MLAB) United States $0.918B 48.07
Tactile Systems Technology (TCMD) United States $0.876B 81.38
Natus Medical (NTUS) United States $0.835B 19.59
CryoLife (CRY) United States $0.702B 60.06
OrthoPediatrics (KIDS) United States $0.699B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.582B 20.65
Accelerate Diagnostics (AXDX) United States $0.493B 0.00
Pacific Biosciences Of California (PACB) United States $0.459B 0.00
Quotient (QTNT) Switzerland $0.430B 0.00
ViewRay (VRAY) United States $0.403B 0.00
AngioDynamics (ANGO) United States $0.374B 24.88
GenMark Diagnostics (GNMK) United States $0.367B 0.00
Si-Bone (SIBN) United States $0.362B 0.00
Intersect ENT (XENT) United States $0.355B 0.00
TransMedics (TMDX) United States $0.322B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.275B 0.00
Alphatec Holdings (ATEC) United States $0.255B 0.00
IRadimed (IRMD) United States $0.240B 27.18
Semler Scientific (SMLR) United States $0.233B 27.85
SeaSpine Holdings (SPNE) United States $0.223B 0.00
Stereotaxis (STXS) United States $0.187B 0.00
Accuray (ARAY) United States $0.182B 0.00
Fluidigm (FLDM) United States $0.139B 0.00
Restoration Robotics (VERO) Canada $0.137B 0.00
RTI Surgical (RTIX) United States $0.134B 36.40
CRH Medical (CRHM) Canada $0.123B 34.30
Electromed (ELMD) United States $0.103B 28.26
Sientra (SIEN) United States $0.092B 0.00
Vermillion (VRML) United States $0.087B 0.00
Spectral Diagnostics (EDTXF) Canada $0.080B 0.00
Allied Healthcare Products (AHPI) United States $0.069B 0.00
EDAP TMS S.A (EDAP) France $0.065B 17.27
MRI Interventions (CLPT) United States $0.060B 0.00
Apollo Endosurgery (APEN) United States $0.048B 0.00
ConforMIS (CFMS) United States $0.047B 0.00
Sensus Healthcare (SRTS) United States $0.040B 0.00
Neuronetics (STIM) United States $0.033B 0.00
Bioanalytical Systems (BASI) United States $0.026B 0.00
T2 Biosystems (TTOO) United States $0.024B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.018B 0.00
TransEnterix (TRXC) United States $0.018B 0.00
Neovasc (NVCN) Canada $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.016B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.016B 0.00
Ra Medical Systems (RMED) United States $0.015B 0.00
Second Sight Medical Products (EYES) United States $0.015B 0.00
Sunshine Heart Inc (CHFS) United States $0.011B 0.00
Nanovibronix (NAOV) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.010B 0.00
Xtant Medical Holdings (XTNT) United States $0.010B 0.00
American Shared Hospital Services (AMS) United States $0.009B 12.50
Viveve Medical (VIVE) United States $0.009B 0.00
Dynatronics (DYNT) United States $0.008B 0.00
Avinger (AVGR) United States $0.007B 0.00
Lianluo Smart (LLIT) China $0.007B 0.00
ReWalk Robotics (RWLK) Israel $0.007B 0.00
Helius Medical Technologies (HSDT) United States $0.007B 0.00
OBALON THERPTCS (OBLN) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
InspireMD (NSPR) Israel $0.003B 0.00